European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...

Tavo Biotherapeutics Secures $17M to advance glaucoma and retinal disease therapies through clinical development and growth.

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

Opus Genetics, Inc. (Nasdaq: IRD) ('Opus Genetics” or the 'Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Nationwide survey finds nearly half of people with inherited retinal disease waited more than five years for genetic ...

An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World ...

Belite Bio, Inc (NASDAQ: BLTE) ('Belite Bio®” or the 'Company”), a clinical-stage drug development company focused on ...

A thin retinal nerve fiber layer (RNFL) may provide a biomarker of cardiovascular-kidney-metabolic syndrome (CKM), even for patients with no history of an ocular or neurodegenerat ...

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

Opus Genetics (NASDAQ:IRD) is advancing a portfolio of gene therapies for inherited retinal diseases, with two programs ...

AI Retinal Imaging and Alzheimer’s Detection. AI retinal imaging could help identify adults needing Alzheimer’s disease referral in primary care settings. AI retinal imaging i ...